In-House Developed VR Platform - AMD, DR, Glaucoma for Visual Impairment

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
NYU Langone Health, New York, NYVisual Impairment+3 MoreIn-House Developed VR Platform - AMD, DR, Glaucoma - Other
Eligibility
18 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial uses virtual reality to simulate different types and severities of visual impairments in order to provide a safe, controllable, and repeatable environment for development and preliminary testing of electronic travel aids.

Eligible Conditions
  • Visual Impairment
  • Glaucoma
  • Age-Related Macular Degeneration
  • Diabetic Retinopathy

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

Study Objectives

9 Primary · 0 Secondary · Reporting Duration: 1 Day of Intervention

1 Day of Intervention
Average distance traveled by the participant
Average number of obstacle collisions during the trial
Average time it takes to understand how to interact with the system and run the simulation of the bus ride
Average time to complete the trial
Average travel time
Number of instances in which the participant stop for more than 2 seconds
Orientation
Preferred walking speed
Total time spent during stops of more than 2 seconds

Trial Safety

Safety Progress

1 of 3

Similar Trials

Trial Design

2 Treatment Groups

Second Set of Experiments
1 of 2
First Set of Experiments
1 of 2

Experimental Treatment

446 Total Participants · 2 Treatment Groups

Primary Treatment: In-House Developed VR Platform - AMD, DR, Glaucoma · No Placebo Group · N/A

Second Set of Experiments
Other
Experimental Group · 1 Intervention: In-House Developed VR Platform - Glaucoma · Intervention Types: Other
First Set of Experiments
Other
Experimental Group · 1 Intervention: In-House Developed VR Platform - AMD, DR, Glaucoma · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 day of intervention

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,279 Previous Clinical Trials
755,845 Total Patients Enrolled
1 Trials studying Visual Impairment
120 Patients Enrolled for Visual Impairment
John-Ross Rizzo, MDPrincipal InvestigatorNYU Langone Health

Eligibility Criteria

Age 18 - 80 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Requirements for patients with vision problems to be included in the study.
You are between the ages of 18 and 80.
The inclusion criteria are as follows: Patient age 18-65 years.
You have any form of glaucoma, no matter how severe or what caused it.
Anyone can participate, regardless of their gender.

Who else is applying?

What state do they live in?
New York81.8%
Pennsylvania9.1%
Florida9.1%
How old are they?
65+100.0%
What portion of applicants met pre-screening criteria?
Met criteria87.5%
Did not meet criteria12.5%

Frequently Asked Questions

What is the ceiling for participants in this investigation?

"Affirmative, clinicaltrials.gov contains proof that this medical trial is currently seeking volunteers and was initially posted on October 24th 2021. The most recent amendment took place on October 6th 2022 with the aim of enrolling 446 patients from one site." - Anonymous Online Contributor

Unverified Answer

Am I eligible to take part in this research endeavor?

"This research project requires the recruitment of 446 glaucoma patients between 18 and 80 years old. Furthermore, potential participants must meet general inclusion criteria as well as possess some form of visual impairment regardless of gender or severity of disease." - Anonymous Online Contributor

Unverified Answer

Is the age range for this research restricted to individuals over 55?

"As specified in the study's requirements for enrolment, individuals must be between 18 and 80 years old to take part." - Anonymous Online Contributor

Unverified Answer

Are any new applicants still being accepted into this investigation?

"Correct. From clinicaltrials.gov, it can be inferred that this medical research has commenced recruitment and is searching for 446 participants from a single site. This project was initially posted on October 24th 2021 with its last update being on the tenth of October 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.